Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention

NOT ENROLLING
Protocol # :
18-294
Conditions
Other Cancer
Phase
Not Applicable
Disease Sites
Neuroendocrine/Carcinoid
Gastroesophageal Junction
Gallbladder/Biliary
Lip, Oral Cavity and Pharynx
Esophagus
Stomach
Small Intestine
Colon
Rectum
Anus
Liver
Pancreas
Other Digestive Organ
Larynx
Lung
Other Respiratory and Intrathoracic Organs
Bones and Joints
Soft Tissue
Mycosis Fungoides
Other Skin
Breast
Cervix
Corpus Uteri
Ovary
Other Female Genital
Prostate
Other Male Genital
Urinary Bladder
Kidney
Other Urinary
Eye and Orbit
Brain and Nervous System
Thyroid
Other Hematopoietic
Unknown Sites
Ill-Defined Sites
Other Endocrine System
Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Multiple Myeloma
Lymphoid Leukemia
Myeloid and Monocytic Leukemia
Leukemia, other
Kaposi's Sarcoma
Melanoma, Skin
Principal Investigator
Bona, Kira, O'Neil

Trial Description

The goal of this new intervention is to make it easier for families to meet their basic
household needs during childhood cancer treatment. The investigators want to learn how to
best use PediCARE to help care for families.

Eligibility Requirements

Inclusion Criteria:

- Child newly diagnosed with cancer within 2 months;

- Planned receipt of at least 4 cycles of chemotherapy at DFCI or UAB;

- Parent/guardian screened positive for HMH*;

- Child is <18 years at time of enrollment

- In accordance with previous research1 families will be operationalized as having HMH
for eligibility purposes if they report at least one of the below four concrete
needs assessed during routine clinical care as follows:

- Food insecurity.

- Housing Insecurity.

- Energy Insecurity.

- Transportation Insecurity.

HMH screening is performed as standard of care by site-specific psychosocial providers.

Exclusion Criteria:

- Child with diagnosis of relapsed cancer;

- Child planned to receive fewer than 4 cycles of chemotherapy

- Child planned to receive observation, radiation or surgical resection only;

- Planned transfer of child to a non-DFCI or UAB facility for chemotherapy treatment;

- Foreign national family receiving cancer care as an Embassy-pay patient;

- Child is enrolled on DFCI 16-001 (due to ongoing embedded descriptive HMH study)

18-294